Rakhi Kumar - 26 Apr 2023 Form 4 Insider Report for Roivant Sciences Ltd. (ROIV)

Role
Chief Accounting Officer
Signature
By: /s/ Jo Chen, as Attorney-in-Fact for Rakhi Kumar
Issuer symbol
ROIV
Transactions as of
26 Apr 2023
Transactions value $
-$1,080,501
Form type
4
Filing time
28 Apr 2023, 21:35:43 UTC
Previous filing
24 Apr 2023
Next filing
03 May 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ROIV Common Shares Options Exercise $211,160 +53,189 +27% $3.97 253,328 26 Apr 2023 Direct
transaction ROIV Common Shares Options Exercise $133,367 +34,641 +14% $3.85 287,969 26 Apr 2023 Direct
transaction ROIV Common Shares Sale -$762,364 -87,830 -30% $8.68 200,139 26 Apr 2023 Direct F1
transaction ROIV Common Shares Options Exercise $21,179 +5,335 +2.7% $3.97 205,474 27 Apr 2023 Direct
transaction ROIV Common Shares Options Exercise $252,690 +65,634 +32% $3.85 271,108 27 Apr 2023 Direct
transaction ROIV Common Shares Sale -$603,946 -70,969 -26% $8.51 200,139 27 Apr 2023 Direct F1
transaction ROIV Common Shares Options Exercise $277,157 +71,989 +36% $3.85 272,128 28 Apr 2023 Direct
transaction ROIV Common Shares Sale -$609,746 -71,989 -26% $8.47 200,139 28 Apr 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ROIV Stock Option (Right to Buy) Options Exercise $0 -53,189 -91% $0 5,335 26 Apr 2023 Common Shares 53,189 $3.97 Direct F2
transaction ROIV Stock Option (Right to Buy) Options Exercise $0 -34,641 -3.5% $0 965,359 26 Apr 2023 Common Shares 34,641 $3.85 Direct F3
transaction ROIV Stock Option (Right to Buy) Options Exercise $0 -5,335 -100% $0* 0 27 Apr 2023 Common Shares 5,335 $3.97 Direct F2
transaction ROIV Stock Option (Right to Buy) Options Exercise $0 -65,634 -6.8% $0 899,725 27 Apr 2023 Common Shares 65,634 $3.85 Direct F3
transaction ROIV Stock Option (Right to Buy) Options Exercise $0 -71,989 -8% $0 827,736 28 Apr 2023 Common Shares 71,989 $3.85 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The price reported in column 4 is a weighted average price. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Common Shares sold at each separate price within the range set forth in this footnote (1) to this Form 4. These sales were effected by the reporting person pursuant to a Rule 10b5-1 trading plan adopted on February 25, 2023.
F2 Award of stock options to purchase Common Shares that was fully vested.
F3 Award of stock options to purchase Common Shares with a vesting commencement date of April 20, 2022. These options vest and become exercisable (i) 25% on the first anniversary of the applicable vesting commencement date and (ii) in 36 equal monthly installments thereafter, subject generally to the reporting person's continuous service through each vesting date (unless otherwise provided in the applicable award documentation).